Wellorithm review

Start with the second payment

The current semaglutide plan lists $179 for the first payment and $299 for each following month. Tirzepatide lists $279 initially and $399 monthly afterward. Consultation and shipping are included on the cards. ^[2] I would compare the continuing prices first, because an attractive opening invoice does not establish whether ongoing care is affordable.

The October 30 terms specify calendar-month billing for these compounded injectable plans, with twelve payments for twelve consecutive months and no additional membership fee. ^[3] That is useful for a fixed monthly budget. Keep the actual renewal date and selected prescription together: medication instructions and clinical refill requirements can still differ from the billing interval.

The pricing table has a defined scope

The table identifies compounded injections and says the price stays the same across its listed dose ranges, with the clinician determining the prescription. It separately describes branded GLP-1 care at a $49 monthly service fee, with medication dependent on coverage, pharmacy and treatment. ^[2] These are different offers. The branded service fee is not a complete drug bill, and the compounded-plan price should not be assigned to another formulation.

I would compare like with like: exact prescription, visit or membership charge, medication, delivery and billing interval. If insurance is the reason for considering a brand, get the benefit determination before treating an estimated price as a realistic budget. If a compound is being considered, the preparation and follow-up belong in the comparison alongside the rate. Flat dose pricing is a commercial feature, not a reason to increase a dose or bypass review of tolerability.

The cancellation window needs room for a decision

Wellorithm says plans renew automatically and require cancellation through the account or support at least forty-eight hours before the next renewal charge. If treatment is not prescribed, the medication portion is not charged, although a consultation fee may be retained for the review. ^[2] I would confirm the selected plan’s initial total and keep the deadline with the receipt rather than assuming an unsuccessful assessment necessarily costs nothing.

For continuing care, schedule any question about changing or stopping the commercial plan early enough that the clinician and billing team can respond. A support message sent near renewal is not the same as completed cancellation. At the same time, turning off automatic payment should not stand in for a clinical plan about medication. Clear separation of those decisions protects both the budget and the treatment record.

Under the October 30 terms, an unsuccessful initial evaluation means the medication amount is not captured or is refunded. Only a separately disclosed, itemized, earned and lawful consultation fee may be retained. Cancellation alone does not create a prorated current-term refund, with eligibility, accepted guarantees, billing corrections and legal remedies treated separately. ^[3]

A weight-loss refund guarantee applies only where included in the accepted offer. The terms describe eligible new customers with less than 10% loss after sixteen weeks of adherence, no other weight-loss medication in the preceding year and verification requirements; the possible refund is up to four months of fees actually paid. This is a conditional financial remedy, not a forecast of clinical benefit or an entitlement for every enrollee. ^[3]

For the outcome beyond a smaller weight reading, read weight loss, lean mass and physical function.

The wider wellness catalog should not choose the treatment

Wellorithm’s homepage also lists NAD injections, a GLP tablet category and a peptides-and-longevity category. ^[1] I would keep those out of the price comparison unless one is the exact intervention under consideration. The detailed injectable pricing table does not establish a NAD quote or validate a different route. Its explicit disclosure that compounded medications are not FDA-approved also belongs beside the product decision. ^[2]

Choose Wellorithm for the clarity of the selected plan, not for the suggestion that more therapeutic categories create a more complete healthy-aging program. A useful weight-care service should make follow-up manageable and keep function, eating and tolerability visible alongside weight. If you already have reliable prescribing elsewhere, decide what would improve before moving. The strongest reason to switch is a concrete gain in access or complete cost; a new collection of wellness claims is a weaker reason to start another prescription.

For why continuing access belongs in the budget, consider what happens when GLP-1 treatment stops.

For the boundary between weight loss and a clinical-outcome claim, read what SELECT established about cardiovascular outcomes.

Use the written offer as a practical reference

When a site sells both branded and compounded pathways, I would save the selected plan description with the order confirmation. That gives you a reference for what was included, which interval applies and which question belongs with billing. It also makes a later comparison easier if the clinician recommends changing the product. Do not rely on a memory of the lowest number on the page. For the healthspan reader, the best financial plan is one that supports appropriate continuing care without making every follow-up a new negotiation over what the original advertisement meant. A clear offer should remain clear after the first payment.

For a distinct midlife care arrangement, compare our Alloy review.

Compare the selected paid schedule in the cost planner.

For another biomarker and follow-up arrangement, read our Hone Health review.

Understanding the cost

Current compounded injectable semaglutide $179 first payment/$299 each following calendar month; tirzepatide $279/$399. Evaluation, prescribed medicine, shipping and follow-up listed as included; no additional membership fee for these plans. Branded insurance support $49/month excludes medication and may involve separately disclosed coordination fees. Confirm selected order, clinical eligibility and charge date. ^{[2] [3]}